학술논문

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
Document Type
Journal
Source
FRONTIERS IN PHARMACOLOGY; MAY 23 2023, 14 p1117293 12p.
Subject
Language
English
ISSN
16639812